Stephan Christgau is a founding partner of Eir Ventures, a €122m life sciences venture firm backed by six Swedish universities and, through a sidecar vehicle, University of Copenhagen. He joins us on Talking Tech Transfer to discuss the opportunities and challenges of investing across multiple countries, and ponders the unique strengths that the Nordics have in pharmaceutical.

Christgau, who previously helped establish and run corporate venturing unit Novo Seeds for 12 years, also talks about the importance of training the next generation of investors and why it is crucial to have diversity in fund and company management teams.

Follow Thierry Heles on LinkedIn.

“Funk Game Loop” Kevin MacLeod (incompetech.com) • Licensed under Creative Commons: By Attribution 3.0